Ministry of National Health Services, Regulations and Coordination

Drug Regulatory Authority of Pakistan

National Control Laboratory for Biologicals

Home Up DBER About Us Search Contents FAQs

Measels vaccine

All function of NCLB are now under DRAP Act, 2012 (Act No. XXI of 2012) and all previous actions and SROs are protected.

Lot Release is now under Schedule I, and NCLB is part of DRAP under Section 3 of this Act.

For detailed description of various aspects of DRAP Act, 2012 visit this link


DRAP Act, 2012 pdf file. 



Manufactured by NIH, Islamabad WHO TRS
Manufactured by growing measles virus on the SPF eggs. The final product is a purified, stabilized and freeze-dried vaccine. The technical specifications are according to WHO specifications. Requirements for measles, mumps and rubella vaccines and combined vaccine (live)
Technical Report Series, No. 840, 1994, Annex 3
  Measles, mumps and rubella vaccines and combined vaccines, live Title: Requirements for Measles, Mumps and Rubella Vaccines and Combined Vaccines, (Live); Adopted 1992, TRS No 840, Annex 3;
Note TRS No 848
  Position paper


Home ] Up ]

Send mail to with questions or comments about this web site.
Copyright 2011 National Control Laboratory for Biologicals
Last modified: 17-Mar-2015